SitemapImpressumDatenschutzerklärungdeutschenglish
MHH Logo

2004

Tammen H, Mohring T, Kellmann M, Pich A, Kreipe HH, Hess R

Mass spectrometric phenotyping of Val34Leu polymorphism of blood coagulation factor XIII by differential peptide display.

Clin Chem 2004;50;545-551

Abstract

 

Makdessi K, Fritsche K, Pich A, Andreesen JR

Identification and characterization of the cytoplasmic tungstate/molybdate-binding protein (Mop) from Eubacterium acidaminophilum.

Arch Microbiol 2004;181;45-51

Abstract

 

Rauh D, Graentzdoerffer A, Granderath K, Andreesen JR, Pich A

Tungsten-containing aldehyde oxidoreductase of Eubacterium acidaminophilum.

Eur J Biochem 2004;271;212-219

Abstract

 

Rummel A, Karnath T, Henke T, Bigalke H, Binz T

Synaptotagmins I and II Act as nerve cell receptors for botulinum neurotoxin G.

J Biol Chem 2004;279(29);30865-70

Abstract

 

Kaiser T, Wittke S, Just I, Krebs R, Bartel S, Fliser D, Mischak H, Weissinger EM

Capillary electrophoresis coupled to mass spectrometer for automated and robust polypetide determination in body fluids for clinical use.

Electrophoresis 2004;25;2044-2055

Abstract

 

Ahnert-Hilger G, Höltje M, Große G, Pickert G, Mucke C., Nixdorf-Bergweiler B, Boquet P, Hofmann F, Just I

Differential effects of Rho GTPases on axonal and dendritic development in hippocampal neurons.

J Neurochem 2004;90;9-18

Abstract

 

Reisinger C, Yelamanchili SV, Hinz B, Mitter D, Becher A, Bigalke H, Ahnert-Hilger G

The synaptophysin/synaptobrevin complex dissociates independently of neuroexocytosis

J Neurochem 2004;90;1-8

Abstract

 

Herrmann J, Geth K, Mall V, Bigalke H, Schulte Monting J, Linder M, Kirschner J, Berweck S, Korinthenberg R, Heinen F, Fietzek UM

Clinical impact of antibody formation to botulinum toxin A in children.

Ann Neurol 2004;55(5);732-5

Abstract

 

Bigalke H, Dressler D, Jankovic J

Basic and therapeutic aspects of neurotoxins.

Mov Disord 2004;19(S8);1

Abstract

 

Wohlfarth K, Kampe K, Bigalke H

Pharmacokinetic properties of different formulations of botulinum neurotoxin type A.

Mov Disord 2004 Mar;19(S8);65-7

Abstract

 

Rummel A, Mahrhold S, Bigalke H, Binz T

The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction.

Mol Microbiol 2004;51(3);631-43

Abstract